These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25585680)

  • 1. Preclinical data reproducibility for R&D--the challenge for neuroscience.
    Steckler T
    Psychopharmacology (Berl); 2015 Jan; 232(2):317-20. PubMed ID: 25585680
    [No Abstract]   [Full Text] [Related]  

  • 2. Key considerations in the preclinical development of biosimilars.
    Bui LA; Hurst S; Finch GL; Ingram B; Jacobs IA; Kirchhoff CF; Ng CK; Ryan AM
    Drug Discov Today; 2015 May; 20 Suppl 1():3-15. PubMed ID: 25912284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Critical Path to New Medicines: data sharing.
    Altern Lab Anim; 2006 Jun; 34(3):273-4. PubMed ID: 16874922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Developability assessment with case studies highlighting the decision taking].
    Dumas J; Sévérac A; Lemoine C; Huille S; Rak A; Prades C
    Med Sci (Paris); 2019 Dec; 35(12):1171-1174. PubMed ID: 31903933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan drug development is not taking off.
    Joppi R; Bertele V; Garattini S
    Br J Clin Pharmacol; 2009 May; 67(5):494-502. PubMed ID: 19552743
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectivity of data obtention previous to drug commercialization: utopy or reality?].
    Soto Alvarez J
    Med Clin (Barc); 2006 Nov; 127(19):736-7. PubMed ID: 17198650
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroscience: Standard model.
    Schnabel J
    Nature; 2008 Aug; 454(7205):682-5. PubMed ID: 18685674
    [No Abstract]   [Full Text] [Related]  

  • 9. Commercial reference shape standards use in the study of particle shape effect on laser diffraction particle size analysis.
    Kelly RN; Kazanjian J
    AAPS PharmSciTech; 2006 May; 7(2):E49. PubMed ID: 16796366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology in neuroscience drug discovery: quo vadis?
    Trist DG; Cohen A; Bye A
    Curr Opin Pharmacol; 2014 Feb; 14():50-3. PubMed ID: 24565012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug target validation: Hitting the target.
    Smith C
    Nature; 2003 Mar; 422(6929):341, 343, 345 passim. PubMed ID: 12646927
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevating standards for discoveries reported in ACS Chemical Neuroscience: new criteria to enhance reproducibility, experimental transparency, reliability, and the value of negative data.
    Lindsley CW
    ACS Chem Neurosci; 2014 Oct; 5(10):868-9. PubMed ID: 25315492
    [No Abstract]   [Full Text] [Related]  

  • 13. The preclinical data forum network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience.
    Steckler T; Brose K; Haas M; Kas MJ; Koustova E; Bespalov A;
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1803-7. PubMed ID: 26073278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI in preclinical drug development.
    Silva MD; Chandra S
    Methods Mol Med; 2006; 124():299-322. PubMed ID: 16506427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapolation of preclinical data into clinical reality translational science.
    Singer T
    Ernst Schering Res Found Workshop; 2007; (59):1-5. PubMed ID: 17117711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening: a real screening complement to high-throughput screening.
    Mestres J
    Biochem Soc Trans; 2002 Aug; 30(4):797-9. PubMed ID: 12196200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High drug attrition rates--where are we going wrong?
    Hutchinson L; Kirk R
    Nat Rev Clin Oncol; 2011 Mar; 8(4):189-90. PubMed ID: 21448176
    [No Abstract]   [Full Text] [Related]  

  • 18. Tackling reproducibility in academic preclinical drug discovery.
    Frye SV; Arkin MR; Arrowsmith CH; Conn PJ; Glicksman MA; Hull-Ryde EA; Slusher BS
    Nat Rev Drug Discov; 2015 Nov; 14(11):733-4. PubMed ID: 26388229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug hunt.
    Hoag H
    Nature; 2006 Feb; 439(7078):886-7. PubMed ID: 16506321
    [No Abstract]   [Full Text] [Related]  

  • 20. Should preclinical studies be registered?
    Kimmelman J; Anderson JA
    Nat Biotechnol; 2012 Jun; 30(6):488-9. PubMed ID: 22678379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.